CD276 and non-small cell lung carcinoma: The upregulation of B7H3 expression has been observed in various malignant neoplasms, including non-small cell lung cancer (NSCLC), renal, urothelial, prostate, gastric, pancreatic, colorectal, and ovarian cancers, as well as osteosarcoma, head and neck squamous carcinoma, and glioblastoma.